Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
712 studies found for:    "Venous Thromboembolism"
Show Display Options
Rank Status Study
21 Withdrawn Systematic Review and Meta-Analysis of Venous Thromboembolism (VTE) Risk Assessment in Hospitalized Medical Patients
Condition: Venous Thromboembolism
Intervention: Other: Application of VTE Risk Assessment
22 Recruiting Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) Scans
Conditions: Cancer;   Venous Thromboembolism
Intervention: Behavioral: Questionnaires
23 Completed
Has Results
Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery
Condition: Venous Thromboembolism
Interventions: Drug: DU-176b (edoxaban);   Drug: Enoxaparin  sodium 20mg
24 Not yet recruiting Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery
Condition: Venous Thromboembolism
Interventions: Drug: Sodium enoxaparin;   Drug: Sodium Enoxaparin clexane
25 Completed
Has Results
A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
Conditions: Venous Thromboembolism;   Thromboembolism;   Thrombosis;   Embolism and Thrombosis;   Deep Vein Thrombosis;   Arthroplasty, Replacement, Hip
Interventions: Drug: DU-176b 15mg;   Drug: DU-176b 30mg;   Drug: Enoxaparin sodium 20 mg (=2000IU)
26 Completed
Has Results
A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
Conditions: Prevention;   Venous Thromboembolism
Interventions: Drug: edoxaban;   Drug: enoxaparin sodium
27 Enrolling by invitation Multicenter Registry for Comparative Effectiveness Analysis of Venous Thromboembolism in Trauma Patients
Conditions: Venous Thromboembolism;   Pulmonary Embolus;   Deep Vein Thrombosis
Intervention:
28 Completed
Has Results
A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Total Knee Arthroplasty
Interventions: Drug: DU-176b;   Drug: Placebo
29 Completed A Study to Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery
Condition: Venous Thromboembolism
Interventions: Drug: YM150;   Procedure: mechanical prophylaxis
30 Completed Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer
Condition: Venous Thromboembolism
Intervention:
31 Recruiting VTEval Project - A Prospective Cohort Study to Evaluate Diagnosis, Management and Outcome in Individuals With Venous Thromboembolism
Conditions: Venous Thromboembolism (VTE);   Deep Vein Thrombosis (DVT);   Pulmonary Embolism (PE)
Intervention:
32 Unknown  Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery
Condition: Venous Thromboembolism
Interventions: Drug: Dabigatran;   Drug: Rivaroxaban;   Drug: Nadroparin
33 Active, not recruiting Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Conditions: Deep Vein Thrombosis;   Venous Thrombosis;   Postphlebitic Syndrome;   Venous Thromboembolism;   Post Thrombotic Syndrome
Intervention: Drug: Recombinant tissue plasminogen activator (rt-PA)
34 Completed
Has Results
The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma
Condition: Venous Thromboembolism
Interventions: Drug: Dalteparin sodium;   Drug: Dalteparin sodium/aspirin
35 Recruiting Optimal Duration of Anticoagulation in Deep Venous Thrombosis
Conditions: Deep Venous Thrombosis of the Lower Extremities;   Symptomatic Recurrent Venous Thromboembolism
Intervention: Drug: Sodium warfarin
36 Completed Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery
Condition: Venous Thromboembolism
Interventions: Drug: Semuloparin Sodium;   Drug: Enoxaparin sodium;   Drug: Placebo
37 Active, not recruiting A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis
Conditions: Deep Vein Thrombosis;   Coronary Artery Bypass Surgery;   Venous Thromboembolism
Interventions: Drug: Fondaparinux;   Other: Placebo
38 Terminated
Has Results
Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients
Condition: Venous Thromboembolism
Interventions: Drug: Dalteparin (Fragmin);   Drug: Unfractionated heparin
39 Completed Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients
Conditions: Venous Thromboembolism;   Deep-Vein Thrombosis;   Pulmonary Embolism;   Cancer
Intervention:
40 Completed Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery
Condition: Venous Thromboembolism
Interventions: Drug: Semuloparin sodium;   Drug: Placebo (for Enoxaparin sodium);   Drug: Enoxaparin sodium;   Drug: Placebo (for Semuloparin sodium)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years